DOI QR코드

DOI QR Code

Protective effects of lutein against vancomycin-induced acute renal injury in mice via upregulation of peroxisome proliferator-activated receptor gamma/nuclear factor erythroid 2-related factor 2 and inhibition nuclear factor-kappaB/caspase 3

  • Emeka, Promise M. (Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University) ;
  • Rasool, Sahibzada T. (Department of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University) ;
  • Morsy, Mohamed A. (Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University) ;
  • Islam, Mohamed I. Hairul (Department of Biological Sciences, College of Science, King Faisal University) ;
  • Chohan, Muhammad S. (Department of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University)
  • Received : 2020.10.26
  • Accepted : 2021.04.05
  • Published : 2021.07.01

Abstract

Vancomycin, an antibiotic used occasionally as a last line of treatment for methicillin-resistant Staphylococcus aureus, is reportedly associated with nephrotoxicity. This study aimed at evaluating the protective effects of lutein against vancomycin-induced acute renal injury. Peroxisome proliferator-activated receptor gamma (PPARγ) and its associated role in renoprotection by lutein was also examined. Male BALB/c mice were divided into six treatment groups: control with normal saline, lutein (200 mg/kg), vancomycin (250 mg/kg), vancomycin (500 mg/kg), vancomycin (250 mg/kg) with lutein, and vancomycin (500 mg/kg) with lutein groups; they were euthanized after 7 days of treatment. Thereafter, samples of blood, urine, and kidney tissue of the mice were analyzed, followed by the determination of levels of N-acetyl-β-D-glucosaminidase (NAG) in the urine, renal creatine kinase; protein carbonyl, malondialdehyde, and caspase-3 in the kidney; and the expression of PPARγ, nuclear factor erythroid 2-related factor 2 (Nrf2), and nuclear factor-kappaB (NF-κB) in renal tissue. Results showed that the levels of protein carbonyl and malondialdehyde, and the activity of NAG, creatine kinase and caspase-3, were significantly increased in the vancomycin-treatment groups. Moreover, the levels of Nrf2 significantly decreased, while NF-κB expression increased. Lutein ameliorated these effects, and significantly increased PPARγ expression. Furthermore, it attenuated vancomycin-induced histological alterations such as, tissue necrosis and hypertrophy. Therefore, we conclude that lutein protects against vancomycin-induced renal injury by potentially upregulating PPARγ/Nrf2 expression in the renal tissues, and consequently downregulating the pathways: inflammation by NF-κB and apoptosis by caspase-3.

Keywords

Acknowledgement

We hereby wish to thank Deanship of Scientific Research, King Faisal University, Saudi Arabia for supporting this research. Also we wish to acknowledge Mr. Tameem Alyahian, our Laboratory Supervisor, for his assistance. We also acknowledge Mr. Sami Al-Qaimi for helping us with the procurement of chemicals. This research project was funded by the Deanship of Scientific Research, King Faisal University, Saudi Arabia (grant number: 140237).

References

  1. Jorgensen SCJ, Murray KP, Lagnf AM, Melvin S, Bhatia S, Shamim MD, Smith JR, Brade KD, Simon SP, Nagel J, Williams KS, Ortwine JK, Veve MP, Truong J, Huang DB, Davis SL, Rybak MJ. A multicenter evaluation of vancomycin-associated acute kidney injury in hospitalized patients with acute bacterial skin and skin structure infections. Infect Dis Ther. 2020;9:89-106. https://doi.org/10.1007/s40121-019-00278-1
  2. Dieterich C, Puey A, Lin S, Swezey R, Furimsky A, Fairchild D, Mirsalis JC, Ng HH. Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates. Toxicol Sci. 2009;107:258-269. https://doi.org/10.1093/toxsci/kfn203
  3. Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008;52:1330-1336. https://doi.org/10.1128/AAC.01602-07
  4. Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66:82-98. https://doi.org/10.2146/ajhp080434
  5. Qin X, Tsoi MF, Zhao X, Zhang L, Qi Z, Cheung BMY. Vancomycin-associated acute kidney injury in Hong Kong in 2012-2016. BMC Nephrol. 2020;21:41. https://doi.org/10.1186/s12882-020-1704-4
  6. Nishino Y, Takemura S, Minamiyama Y, Hirohashi K, Ogino T, Inoue M, Okada S, Kinoshita H. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats. Free Radic Res. 2003;37:373-379. https://doi.org/10.1080/1071576031000061002
  7. Suntres ZE. Liposomal antioxidants for protection against oxidant-induced damage. J Toxicol. 2011;2011:152474. https://doi.org/10.1155/2011/152474
  8. Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS. Oxidant mechanisms in renal injury and disease. Antioxid Redox Signal. 2016;25:119-146. https://doi.org/10.1089/ars.2016.6665
  9. Stanton RC. Oxidative stress and diabetic kidney disease. Curr Diab Rep. 2011;11:330-336. https://doi.org/10.1007/s11892-011-0196-9
  10. Kim JE, Clark RM, Park Y, Lee J, Fernandez ML. Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet. Nutr Res Pract. 2012;6:113-119. https://doi.org/10.4162/nrp.2012.6.2.113
  11. Ma Y, Shi M, Wang Y, Liu J. PPARγ and its agonists in chronic kidney disease. Int J Nephrol. 2020;2020:2917474.
  12. Korbecki J, Bobinski R, Dutka M. Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors. Inflamm Res. 2019;68:443-458. https://doi.org/10.1007/s00011-019-01231-1
  13. Selvaraj RK, Klasing KC. Lutein and eicosapentaenoic acid interact to modify iNOS mRNA levels through the PPARgamma/RXR pathway in chickens and HD11 cell lines. J Nutr. 2006;136:1610-1616. https://doi.org/10.1093/jn/136.6.1610
  14. Zhang B, Lo C, Shen L, Sood R, Jones C, Cusmano-Ozog K, ParkSnyder S, Wong W, Jeng M, Cowan T, Engleman EG, Zehnder JL. The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood. 2011;117:4569-4579. https://doi.org/10.1182/blood-2010-09-304931
  15. Garcia-Rojas P, Antaramian A, Gonzalez-Davalos L, Villarroya F, Shimada A, Varela-Echavarria A, Mora O. Induction of peroxisomal proliferator-activated receptor gamma and peroxisomal proliferator-activated receptor gamma coactivator 1 by unsaturated fatty acids, retinoic acid, and carotenoids in preadipocytes obtained from bovine white adipose tissue1,2. J Anim Sci. 2010;88:1801-1808. https://doi.org/10.2527/jas.2009-2579
  16. Qu S, Dai C, Lang F, Hu L, Tang Q, Wang H, Zhang Y, Hao Z. Rutin attenuates vancomycin-induced nephrotoxicity by ameliorating oxidative stress, apoptosis, and inflammation in rats. Antimicrob Agents Chemother. 2018;63:e01545-e01518.
  17. Nakamura T, Hashimoto Y, Kokuryo T, Inui KI. Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats. Pharm Res. 1998;15:734-738. https://doi.org/10.1023/A:1011971019868
  18. Vasudeva V, Tenkanidiyoor YS, Peter AJ, Shetty J, Lakshman SP, Fernandes R, Patali KA. Radioprotective efficacy of lutein in ameliorating electron beam radiation-induced oxidative injury in Swiss albino mice. Iran J Med Sci. 2018;43:41-51.
  19. Horak E, Hopfer SM, Sunderman FW Jr. Spectrophotometric assay for urinary N-acetyl-beta-D-glucosaminidase activity. Clin Chem. 1981;27:1180-1185. https://doi.org/10.1093/clinchem/27.7.1180
  20. Hughes BP. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta. 1962;7:597-603. https://doi.org/10.1016/0009-8981(62)90137-7
  21. Velmurugan G, Venkatesh Babu DD, Ramasamy S. Prolonged monocrotophos intake induces cardiac oxidative stress and myocardial damage in rats. Toxicology. 2013;307:103-108. https://doi.org/10.1016/j.tox.2012.11.022
  22. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358. https://doi.org/10.1016/0003-2697(79)90738-3
  23. Rojas-Franco P, Franco-Colin M, Camargo MEM, Carmona MME, Ortiz-Butron M del R E, Blas-Valdivia V, Cano-Europa E. Phycobiliproteins and phycocyanin of Arthrospira maxima (Spirulina) reduce apoptosis promoters and glomerular dysfunction in mercury-related acute kidney injury. Toxicol Res Appl. 2018;2:1-10.
  24. Ahn SY, Cho CH, Park KG, Lee HJ, Lee S, Park SK, Lee IK, Koh GY. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Am J Pathol. 2004;164:1663-1672. https://doi.org/10.1016/S0002-9440(10)63725-X
  25. Selvaraj RK, Shanmugasundaram R, Klasing KC. Effects of dietary lutein and PUFA on PPAR and RXR isomer expression in chickens during an inflammatory response. Comp Biochem Physiol A Mol Integr Physiol. 2010;157:198-203. https://doi.org/10.1016/j.cbpa.2010.06.172
  26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25:402-408. https://doi.org/10.1006/meth.2001.1262
  27. Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2020;40:363-367. https://doi.org/10.1002/phar.2376
  28. Liu ZG, Qi ZC, Liu WL, Wang WZ. Lutein protects against ischemia/reperfusion injury in rat kidneys. Mol Med Rep. 2015;11:2179-2184. https://doi.org/10.3892/mmr.2014.2982
  29. Yoshiyama Y, Yazaki T, Wong PC, Beauchamp D, Kanke M. The effect of fosfomycin on glycopeptide antibiotic-induced nephrotoxicity in rats. J Infect Chemother. 2001;7:243-246. https://doi.org/10.1007/s101560170020
  30. Nair SV, Ghanam K, Deshpande J, Juturu V. Lutein and zeaxanthin isomers induces mitochondrial biogenesis and improves endurance capacity in muscle cells. EC Ophthalmol. 2018;9:658-668.
  31. Ouyang B, Li Z, Ji X, Huang J, Zhang H, Jiang C. The protective role of lutein on isoproterenol-induced cardiac failure rat model through improving cardiac morphology, antioxidant status via positively regulating Nrf2/HO-1 signalling pathway. Pharm Biol. 2019;57:529-535. https://doi.org/10.1080/13880209.2019.1649436
  32. Cheng F, Zhang Q, Yan FF, Wan JF, Lin CS. Lutein protects against ischemia/reperfusion injury in rat skeletal muscle by modulating oxidative stress and inflammation. Immunopharmacol Immunotoxicol. 2015;37:329-334. https://doi.org/10.3109/08923973.2015.1049704
  33. Buonocore D, Rucci S, Vandoni M, Negro M, Marzatico F. Oxidative system in aged skeletal muscle. Muscles Ligaments Tendons J. 2012;1:85-90.
  34. Kim DH, Kwack SJ, Yoon KS, Choi JS, Lee BM. 4-hydroxynonenal: a superior oxidative biomarker compared to malondialdehyde and carbonyl content induced by carbon tetrachloride in rats. J Toxicol Environ Health A. 2015;78:1051-1062. https://doi.org/10.1080/15287394.2015.1067505
  35. Havasi A, Borkan SC. Apoptosis and acute kidney injury. Kidney Int. 2011;80:29-40. https://doi.org/10.1038/ki.2011.120
  36. Yang B, El Nahas AM, Thomas GL, Haylor JL, Watson PF, Wagner B, Johnson TS. Caspase-3 and apoptosis in experimental chronic renal scarring. Kidney Int. 2001;60:1765-1776. https://doi.org/10.1046/j.1523-1755.2001.00013.x
  37. Nataraj J, Manivasagam T, Thenmozhi AJ, Essa MM. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress. Nutr Neurosci. 2016;19:237-246. https://doi.org/10.1179/1476830515y.0000000010
  38. Fung FK, Law BY, Lo AC. Lutein attenuates both apoptosis and autophagy upon cobalt (II) chloride-induced hypoxia in rat Muller cells. PLoS One. 2016;11:e0167828. https://doi.org/10.1371/journal.pone.0167828
  39. Yamashita M, Yoshida T, Suzuki S, Homma K, Hayashi M. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice. Clin Exp Nephrol. 2017;21:16-26. https://doi.org/10.1007/s10157-016-1268-6
  40. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1:a001651. https://doi.org/10.1101/cshperspect.a001651
  41. Xiao Z, Shan J, Li C, Luo L, Lu J, Li S, Long D, Li Y. Mechanisms of cyclosporine-induced renal cell apoptosis: a systematic review. Am J Nephrol. 2013;37:30-40. https://doi.org/10.1159/000345988
  42. Jung ME, Gatch MB, Simpkins JW. Estrogen neuroprotection against the neurotoxic effects of ethanol withdrawal: potential mechanisms. Exp Biol Med (Maywood). 2005;230:8-22. https://doi.org/10.1177/153537020523000102
  43. Buhrmann C, Mobasheri A, Busch F, Aldinger C, Stahlmann R, Montaseri A, Shakibaei M. Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem. 2011;286:28556-28566. https://doi.org/10.1074/jbc.M111.256180
  44. Corrales P, Izquierdo-Lahuerta A, Medina-Gomez G. Maintenance of kidney metabolic homeostasis by PPAR gamma. Int J Mol Sci. 2018;19:2063. https://doi.org/10.3390/ijms19072063
  45. Zhang YF, Wang Q, Su YY, Wang JL, Hua BJ, Yang S, Feng JX, Li HY. PPAR-γ agonist rosiglitazone protects rat peritoneal mesothelial cells against peritoneal dialysis solution-induced damage. Mol Med Rep. 2017;15:1786-1792. https://doi.org/10.3892/mmr.2017.6196
  46. Diep QN, Schiffrin EL. Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats. Hypertension. 2001;38:249-254. https://doi.org/10.1161/01.hyp.38.2.249
  47. Kvandova M, Barancik M, Balis P, Puzserova A, Majzunova M, Dovinova I. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of prehypertensive rats. J Physiol Pharmacol. 2018;69:231-243.
  48. Cho HY, Gladwell W, Wang X, Chorley B, Bell D, Reddy SP, Kleeberger SR. Nrf2-regulated PPARγ expression is critical to protection against acute lung injury in mice. Am J Respir Crit Care Med. 2010;182:170-182. https://doi.org/10.1164/rccm.200907-1047OC
  49. Lee C. Collaborative power of Nrf2 and PPARγ activators against metabolic and drug-induced oxidative injury. Oxid Med Cell Longev. 2017;2017:1378175.
  50. Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci. 2014;39:199-218. https://doi.org/10.1016/j.tibs.2014.02.002
  51. Mahmoud AM, Germoush MO, Alotaibi MF, Hussein OE. Possible involvement of Nrf2 and PPARγ up-regulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity. Biomed Pharmacother. 2017;86:297-306. https://doi.org/10.1016/j.biopha.2016.12.047
  52. Makarov SS. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today. 2000;6:441-448. https://doi.org/10.1016/S1357-4310(00)01814-1
  53. Jin XH, Ohgami K, Shiratori K, Suzuki Y, Hirano T, Koyama Y, Yoshida K, Ilieva I, Iseki K, Ohno S. Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci. 2006;47:2562-2568. https://doi.org/10.1167/iovs.05-1429
  54. Jesse CR, Bortolatto CF, Wilhelm EA, Roman SS, Prigol M, Nogueira CW. The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice. J Appl Toxicol. 2014;34:25-32. https://doi.org/10.1002/jat.2818
  55. Ibrahim MA, El-Sheikh AA, Khalaf HM, Abdelrahman AM. Protective effect of peroxisome proliferator activator receptor (PPAR)-α and -γ ligands against methotrexate-induced nephrotoxicity. Immunopharmacol Immunotoxicol. 2014;36:130-137. https://doi.org/10.3109/08923973.2014.884135
  56. Rafi MM, Kanakasabai S, Gokarn SV, Krueger EG, Bright JJ. Dietary lutein modulates growth and survival genes in prostate cancer cells. J Med Food. 2015;18:173-181. https://doi.org/10.1089/jmf.2014.0003